Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR)

CONCLUSION: Tezepelumab reduced exacerbations across all seasons versus placebo in patients with severe, uncontrolled asthma, including patients with seasonal and perennial allergies. These data further support the efficacy of tezepelumab in a broad population of patients with severe, uncontrolled asthma.PMID:37619779 | DOI:10.1016/j.anai.2023.08.015

Source: Annals of Allergy, Asthma and Immunology - August 24, 2023 Category: Allergy & Immunology Authors: Ian D Pavord Flavia C L Hoyte Andrew W Lindsley Christopher S Ambrose Joseph D Spahn Stephanie L Roseti Bill Cook Janet M Griffiths Åsa Hellqvist Nicole Martin Jean-Pierre Llanos Neil Martin Gene Colice Jonathan Corren Source Type: research